New hope for alcohol addiction? popular Weight-Loss drug tested in combo therapy
NCT ID NCT07249554
Summary
This study aims to see if combining two medications, semaglutide (a drug also used for weight loss) and naltrexone (an existing treatment for alcohol use disorder), is safe and more effective than naltrexone alone. It will involve 45 adults already enrolled in a 4-week inpatient treatment program for alcohol use disorder. Participants will take the medications for two weeks while researchers measure cravings, health effects, and other behaviors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Ashley Addiction Treatment
Havre de Grace, Maryland, 21078, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.